Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Novo Nordisk has earnt yet another dressing down from the PMCPA. The U.K. | Novo Nordisk has earnt yet another dressing down ...

Shares of BioAge Labs (BIOA), a biopharmaceutical company focused on obesity drugs, opened 25% above its initial public ...

five times that on the brand name drug,” Noom CEO Geoff Cook said of the prices for his company’s compounded semaglutide.

Robert F. Kennedy Jr. criticized Ozempic and Danish pharmaceutical company Novo Nordisk, arguing that fixing the food supply ...

Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.

James Corden revealed that he gave Ozempic a try to help with weight loss, but soon found that his relationship with food had little to do with how hungry he was or wasn't.

An emerging market for compounded weight loss injections that mimic brand-name drugs such as Ozempic, Wegovy, Mounjaro and ...

On Tuesday, U.S. Senator Mike Braun (R-Ind.) questioned Novo Nordisk CEO Lars Fruergaard Jørgensen at the Senate Health, ...

By Arasu Kannagi Basil and Prakhar Srivastava (Reuters) -Shares of BioAge Labs opened 25% above their initial public offering price on Thursday in a strong debut for the weight-loss drug developer ...